Deerfield Management Company L.P. Series C Takes Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

Deerfield Management Company L.P. Series C bought a new position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 7,072 shares of the company’s stock, valued at approximately $203,000.

Other large investors also recently modified their holdings of the company. Quest Partners LLC purchased a new stake in OrthoPediatrics in the 2nd quarter worth approximately $34,000. EntryPoint Capital LLC boosted its holdings in OrthoPediatrics by 56.9% in the first quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock valued at $81,000 after acquiring an additional 1,009 shares in the last quarter. SG Americas Securities LLC purchased a new position in OrthoPediatrics during the 2nd quarter valued at $110,000. State Board of Administration of Florida Retirement System bought a new position in OrthoPediatrics in the 1st quarter worth $178,000. Finally, Quantbot Technologies LP lifted its position in shares of OrthoPediatrics by 180.8% in the 1st quarter. Quantbot Technologies LP now owns 7,091 shares of the company’s stock worth $207,000 after purchasing an additional 4,566 shares during the period. 69.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. JMP Securities reiterated a “market outperform” rating and set a $50.00 price target on shares of OrthoPediatrics in a research report on Friday, September 13th. Needham & Company LLC reiterated a “buy” rating and issued a $42.00 price objective on shares of OrthoPediatrics in a report on Friday, September 13th. Finally, Truist Financial restated a “hold” rating and set a $34.00 target price (up previously from $30.00) on shares of OrthoPediatrics in a report on Friday, September 13th.

OrthoPediatrics Stock Performance

OrthoPediatrics stock opened at $26.46 on Friday. OrthoPediatrics Corp. has a twelve month low of $23.10 and a twelve month high of $36.23. The company has a quick ratio of 1.96, a current ratio of 4.90 and a debt-to-equity ratio of 0.03. The company has a market capitalization of $630.52 million, a P/E ratio of -27.56 and a beta of 1.18. The stock’s 50 day moving average is $29.88 and its 200 day moving average is $30.16.

OrthoPediatrics (NASDAQ:KIDS) last released its earnings results on Monday, August 5th. The company reported ($0.23) EPS for the quarter, topping analysts’ consensus estimates of ($0.31) by $0.08. The firm had revenue of $52.80 million for the quarter, compared to analysts’ expectations of $52.40 million. OrthoPediatrics had a negative return on equity of 5.44% and a negative net margin of 14.35%. On average, equities research analysts predict that OrthoPediatrics Corp. will post -0.92 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, General Counsel Daniel J. Gerritzen sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $29.30, for a total value of $293,000.00. Following the transaction, the general counsel now owns 77,304 shares in the company, valued at $2,265,007.20. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 31.80% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.